Literature DB >> 18697532

Quantitative accuracy of PET/CT for image-based kinetic analysis.

Youngho Seo1, Boon-Keng Teo, Mohiuddin Hadi, Carole Schreck, Stephen L Bacharach, Bruce H Hasegawa.   

Abstract

Accuracy in quantification of activity concentrations (e.g., in Bq/ml) is essential for compartment modeling and kinetic analysis of dynamic reconstructed PET images. Dynamic PET data can be acquired in list-mode, and often are preferred over frame mode acquisitions due to the flexibility of reformatting the list-mode data into different dynamic image sequences after the acquisition is complete. However, most PET data are acquired as static frames. It therefore is important to evaluate the quantitative accuracy of list-mode or dynamic PET acquisitions prior to their use for clinical or research applications. The quantitative accuracy of list-mode acquisitions obtained with a Siemens Biograph 16 PET/CT scanner at our institution was evaluated; the image data were acquired from an anthropomorphic phantom (Data Spectrum, Hillsborough, NC) filled with an aqueous solution of 18F-fluorodeoxyglucose (FDG). PET data were acquired with the phantom for the following three different configurations: (1) with nonradioactive water in the body compartment and aqueous solution of 18F-FDG in only a fillable cylindrical insert to simulate the first several seconds of highly concentrated radioactivity within the field of view such as that in major venous or pulmonary vessels or in the cardiac ventricles, (2) with radioactivity throughout the entire body compartment and imaged with 3 min static frames and 12 min in list-mode that was reformatted into four 3-min frames, and (3) with radioactivity throughout the body compartment and imaged in list-mode and reformatted into sequential time frames having durations of 3, 10, 20, 30, 50, and 67 s, respectively (i.e., total of 180 s). All measured concentration values were compared against values acquired from static images or against the actual activity concentrations calculated from the calibrated activities dispensed into the phantom corrected for physical decay of 18F. These analyses demonstrated that the count rate limitation is minimal or negligible as long as there is no more than 370-440 MBq (10-12 mCi) activity entirely within the axial FOV and that list-mode acquisition yields accurate quantitation of activity concentrations over a clinically realistic range of activities. In addition, reformatting a single list-mode acquisition into frames of different durations retains quantitative accuracy with respect to static frame data and compared to the known radionuclide concentration in the phantom. Within these constraints, the list-mode data acquired with the Biograph 16 PET/CT system are quantitatively accurate for image-based kinetic analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18697532      PMCID: PMC2809714          DOI: 10.1118/1.2937439

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  8 in total

1.  PET performance measurements for an LSO-based combined PET/CT scanner using the National Electrical Manufacturers Association NU 2-2001 standard.

Authors:  Yusuf E Erdi; Sadek A Nehmeh; Tim Mulnix; John L Humm; Charles C Watson
Journal:  J Nucl Med       Date:  2004-05       Impact factor: 10.057

Review 2.  The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective.

Authors:  G Lucignani; G Paganelli; E Bombardieri
Journal:  Nucl Med Commun       Date:  2004-07       Impact factor: 1.690

3.  Performance characteristics obtained for a new 3-dimensional lutetium oxyorthosilicate-based whole-body PET/CT scanner with the National Electrical Manufacturers Association NU 2-2001 standard.

Authors:  Marco Brambilla; Chiara Secco; Marco Dominietto; Roberta Matheoud; Gianmauro Sacchetti; Eugenio Inglese
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

4.  Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies.

Authors:  Lioe-Fee de Geus-Oei; Eric P Visser; Paul F M Krabbe; Bas A van Hoorn; Emile B Koenders; Antoon T Willemsen; Jan Pruim; Frans H M Corstens; Wim J G Oyen
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

5.  Evaluation of iterative reconstruction (OSEM) versus filtered back-projection for the assessment of myocardial glucose uptake and myocardial perfusion using dynamic PET.

Authors:  Hanne M Søndergaard; Mette Marie Madsen; Karin Boisen; Morten Bøttcher; Ole Schmitz; Torsten T Nielsen; Hans Erik Bøtker; Søren B Hansen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10-11       Impact factor: 9.236

6.  Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans.

Authors:  Nanette M T Freedman; Senthil K Sundaram; Karen Kurdziel; Jorge A Carrasquillo; Millie Whatley; Joann M Carson; David Sellers; Steven K Libutti; James C Yang; Stephen L Bacharach
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-23       Impact factor: 9.236

Review 7.  PET for in vivo pharmacokinetic and pharmacodynamic measurements.

Authors:  N Gupta; P M Price; E O Aboagye
Journal:  Eur J Cancer       Date:  2002-11       Impact factor: 9.162

8.  Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer.

Authors:  D Visvikis; D Francis; R Mulligan; D C Costa; I Croasdale; S K Luthra; I Taylor; P J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

  8 in total
  3 in total

Review 1.  Precision and accuracy of clinical quantification of myocardial blood flow by dynamic PET: A technical perspective.

Authors:  Jonathan B Moody; Benjamin C Lee; James R Corbett; Edward P Ficaro; Venkatesh L Murthy
Journal:  J Nucl Cardiol       Date:  2015-04-14       Impact factor: 5.952

2.  Dynamic cardiac PET imaging: Technological improvements advancing future cardiac health.

Authors:  Grant T Gullberg; Uttam M Shrestha; Youngho Seo
Journal:  J Nucl Cardiol       Date:  2018-01-31       Impact factor: 5.952

3.  Pharmacokinetic Modeling of 18F-FDOPA PET in the Human Brain for Early Parkinson's Disease

Authors:  Wirunpatch Buratachwatanasiri; Maythinee Chantadisai; Jaruwan Onwanna; Yuda Chongpison; Yothin Rakvongthai; Kitiwat Khamwan
Journal:  Mol Imaging Radionucl Ther       Date:  2021-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.